Lemaitre Vascular (LMAT) Other Non Operating Income (2010 - 2026)
Lemaitre Vascular (LMAT) reported Other Non Operating Income of -$127000.0 for Q1 2026, down 6450.0% year-over-year from $2000.0 in Q1 2025, and up 78.14% quarter-over-quarter from -$581000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Other Non Operating Income (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Other Non Operating Income data on file, last reported at -$127000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$127000.0, down 6450.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$767000.0 (down 1604.44% YoY), and the FY2025 annual result was -$638000.0, down 410.4% from the prior year.
- Other Non Operating Income advanced to -$127000.0 in Q1 2026 per LMAT's latest filing, from -$581000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $384000.0 in Q4 2022 and troughed at -$581000.0 in Q4 2025.
- A 5-year average of -$89941.2 and a median of -$78000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2026: Other Non Operating Income surged 3590.91% in 2022, then plunged 6450.0% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at $384000.0 in 2022, then slumped by 70.05% to $115000.0 in 2023, then slumped by 306.96% to -$238000.0 in 2024, then tumbled by 144.12% to -$581000.0 in 2025, then surged by 78.14% to -$127000.0 in 2026.
- Business Quant data shows LMAT's Other Non Operating Income at -$127000.0 in Q1 2026, -$581000.0 in Q4 2025, and -$306000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127,000.00 |
| Dec 31, 2025 | -581,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -238,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -78,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | -189,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | -425,000.00 |
| Dec 31, 2022 | 384,000.00 |
| Sep 30, 2022 | -266,000.00 |
| Jun 30, 2022 | -403,000.00 |
| Mar 31, 2022 | -40,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -72,000.00 |
| Jun 30, 2021 | -157,000.00 |